V-Co Investors 4 LLC reported a new stake of over 5% in Vivos Therapeutics, Inc. ($VVOS) to the SEC on July 15, 2026, through a Schedule 13D filing. Unlike passive 13G filings, a 13D submission indicates activist intentions – the investor intends to influence the management, policies, or other actions of the company.

Vivos Therapeutics is a medical device company focused on treating sleep-disordered breathing. The entry of V-Co Investors 4 LLC as an activist investor could lead to significant changes within the company, such as strategic, organizational, or operational shifts, with the aim of maximizing shareholder value. Activist investors are known for pushing for performance improvements, sometimes through management changes or asset sales.

Individual traders can monitor these developments in Vivos Therapeutics, as activist involvement may introduce volatility to the stock but could also lead to increased value if the fund's demands are met and result in improvements. It is important to remember that the success of activist moves is not guaranteed, and these processes can be lengthy and complex.